האלבן
eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.
האלבן
eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.
implantable radioactive device + accessories
lavi industrial & medical agencies ltd. - מומחה - treatment of liver tumours / liver cancer
אופדיבו
bristol, myers squibb (israel) limited, israel - nivolumab - תרכיז להכנת תמיסה לאינפוזיה - nivolumab 10 mg/ml - nivolumab
טאגריסו 40 מג
astrazeneca (israel) ltd - osimertinib as mesylate - טבליה - osimertinib as mesylate 40 mg - osimertinib
טאגריסו 80 מג
astrazeneca (israel) ltd - osimertinib as mesylate - טבליה - osimertinib as mesylate 80 mg - osimertinib
טפינלר 50 מג
novartis israel ltd - dabrafenib as mesilate - קפסולה קשיחה - dabrafenib as mesilate 50 mg - dabrafenib
טפינלר 50 מג
novartis israel ltd - dabrafenib as mesilate - קפסולה קשיחה - dabrafenib as mesilate 50 mg - dabrafenib
טפינלר 75 מג
novartis israel ltd - dabrafenib as mesilate - קפסולה קשיחה - dabrafenib as mesilate 75 mg - dabrafenib
לינפארזה 50 מג
astra zeneca (israel) ltd - olaparib - קפסולה קשיחה - olaparib 50 mg - olaparib